Anacure Medical

Company Overview

Snapshot

Founded in January 2024 by Eli Michaeli and Michael Mastai, Anacure Medical operates with 1–10 employees. The company is developing a novel rectal sleeve designed to treat anorectal disease and postoperative complications. In September 2025, Anacure Medical secured pre-seed funding from NGT HealthCare II.

Business overview

Anacure Medical is a pioneering medical device company focused on developing non-invasive solutions for the treatment of anorectal disease and postoperative complications. Its core product is a novel rectal sleeve designed to divert stool, reduce leakage, minimize bacterial load, and promote mucosal healing. This technology aims to provide a simple, effective treatment solution requiring minimal expertise and equipment, enhancing patient comfort and accelerating recovery times. The company operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices and Medical Treatment & Therapeutics categories, with a focus on healthcare providers in Europe and North America.

Company Intelligence Q&A

What is Anacure Medical's primary focus?

Anacure Medical is dedicated to the treatment and cure of anorectal disease and postoperative complications through a non-invasive medical device procedure.

When was Anacure Medical founded?

Anacure Medical was founded in January 2024.

Who are the founders of Anacure Medical?

Anacure Medical was co-founded by Eli Michaeli, who serves as CEO, and Michael Mastai, who is the Scientific Leader.

What is the key technology developed by Anacure Medical?

Anacure Medical has developed a novel rectal sleeve designed to divert stool, reduce leakage, minimize bacterial load, promote mucosal healing, and enhance patient comfort.

Has Anacure Medical received any funding?

In September 2025, Anacure Medical secured pre-seed funding from NGT HealthCare II.